Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

The Journal of Biological Chemistry
W S DavidsonJ M George

Abstract

alpha-Synuclein is a highly conserved presynaptic protein of unknown function. A mutation in the protein has been causally linked to Parkinson's disease in humans, and the normal protein is an abundant component of the intraneuronal inclusions (Lewy bodies) characteristic of the disease. alpha-Synuclein is also the precursor to an intrinsic component of extracellular plaques in Alzheimer's disease. The alpha-synuclein sequence is largely composed of degenerate 11-residue repeats reminiscent of the amphipathic alpha-helical domains of the exchangeable apolipoproteins. We hypothesized that alpha-synuclein should associate with phospholipid bilayers and that this lipid association should stabilize an alpha-helical secondary structure in the protein. We report that alpha-synuclein binds to small unilamellar phospholipid vesicles containing acidic phospholipids, but not to vesicles with a net neutral charge. We further show that the protein associates preferentially with vesicles of smaller diameter (20-25 nm) as opposed to larger (approximately 125 nm) vesicles. Lipid binding is accompanied by an increase in alpha-helicity from 3% to approximately 80%. These observations are consistent with a role in vesicle function at the presyna...Continue Reading

References

Jun 14, 1977·Biochemistry·Y BarenholzR D Carlson
Oct 1, 1991·Brain Research. Molecular Brain Research·L Maroteaux, R H Scheller
Jan 22, 1991·Biochemistry·J Y Letizia, M C Phillips
Jan 1, 1990·Proteins·J P SegrestG M Anantharamaiah
Aug 15, 1988·The Biochemical Journal·P D Thomas, M J Poznansky
Oct 5, 1973·Biochimica Et Biophysica Acta·W C BreckenridgeG Vincendon
Sep 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·L Sokoloff, G H Rothblat
Apr 1, 1983·The Biochemical Journal·D M MichaelsonY Barenholz
Jan 20, 1981·Biochemistry·J W Deutsch, R B Kelly
Jul 21, 1995·The Journal of Biological Chemistry·W S DavidsonM C Phillips
May 23, 1994·FEBS Letters·R JakesM Goedert
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K UédaT Saitoh
Aug 1, 1996·Journal of Neuropathology and Experimental Neurology·M C IrizarryB T Hyman
Mar 17, 1997·Brain Research. Developmental Brain Research·G S WithersD F Clayton
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·D W BorhaniC G Brouillette
Apr 1, 1961·Journal of Neuropathology and Experimental Neurology·H OKAZAKIS M ARONSON

❮ Previous
Next ❯

Citations

Sep 24, 1999·Journal of Neuroscience Research·D F Clayton, J M George
Jul 6, 2000·Journal of Neuroscience Research·J E DudaJ Q Trojanowski
Jul 12, 2002·Human Mutation·Damian C Crowther
Jul 4, 2001·Journal of Neuroscience Research·A SurguchovI Surgucheva
Mar 27, 2012·European Biophysics Journal : EBJ·Prathit Chatterjee, Neelanjana Sengupta
Oct 24, 2006·Amino Acids·A Trostchansky, H Rubbo
Feb 12, 2010·Journal of Bioenergetics and Biomembranes·Karen A LewisPhilip J Thomas
Apr 28, 2012·Current Neurology and Neuroscience Reports·Blake ByersRenee Reijo Pera
May 22, 2013·Current Neurology and Neuroscience Reports·Shawn P AlterGary W Miller
Jul 27, 2007·Cell Biochemistry and Biophysics·Klaus Beyer
Sep 4, 2009·Archives of Pharmacal Research·Jung Rok LeeKwang Pyo Kim
May 8, 2013·Trends in Molecular Medicine·Angélique DeleersnijderVeerle Baekelandt
Oct 3, 2003·Trends in Neurosciences·Kevin Welch, Junying Yuan
Aug 10, 2000·The American Journal of Pathology·L J HsuE Masliah
Sep 10, 2002·Journal of Molecular Biology·Wolfgang HoyerVinod Subramaniam
Jun 20, 2003·Neuropharmacology·Kumlesh K DevHerman van der Putten
Nov 1, 2001·Brain Research. Molecular Brain Research·J E PaytonJ M George
Oct 24, 2002·Neurobiology of Aging·Gianluigi ForloniAlessandro Bertoli
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Oliver Wirths, Thomas A Bayer
Apr 18, 2002·Free Radical Biology & Medicine·Kyung Sik KimJung Hoon Kang
May 29, 2000·Current Opinion in Genetics & Development·H R de SilvaN W Wood
May 30, 2001·Current Opinion in Genetics & Development·M Goedert
Nov 13, 1998·Current Opinion in Neurobiology·M GoedertS W Davies
May 3, 2000·Rinshō shinkeigaku = Clinical neurology·T Iwatsubo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.